| Products |
|
|
 |
| Contact Us |
 |
Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China |
 |
Tel:
Sales: +86-531-88811783
Evaluation:+86-531-88806178
R&D: +86-531-88813691
Office: +86-531-88817621 |
 |
Fax: +86-531-88817925 |
 |
Zip Code: 250101 |
 |
Email:
Trade Department:
sales@trio-pharmatech.com
G&D&E:
register@trio-pharmatech.com
yzxpj@trio-pharmatech.com
R&D center::
newdrugs@trio-pharmatech.com |
|
|
|
| API & Intermediates |
Now Position:Home > Products > API & Intermediates < Anti-cancer API |
|
| Dabrafenib(CAS:1195765-45-7) |
 |
|
|
Product No. |
|
TP1210C |
|
Name |
|
Dabrafenib |
|
Synonyms |
|
N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(tert-butyl)
-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide |
|
Structure |
|
|
|
Formula |
|
C23H20F3N5O2S2 |
|
Mol. Wt. |
|
519.56 |
|
CAS Number |
|
1195765-45-7 |
|
Purity |
|
>99% |
|
|
|
|
|
|
